Stryker’s Wingspan clipped by study showing higher stroke risk versus drug therapy
This article was originally published in Clinica
Stryker’s brain stent system Wingspan has been dealt a blow after a study found that the device, when used to treat clogged arteries in the brain, was linked with an increased risk of stroke and death compared with drug therapy alone. The findings were so emphatic that enrolment in the study was halted early because of safety concerns with Wingspan. The results were published online yesterday in the New England Journal of Medicine.